Shanxi C&Y Pharmaceutical Group Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shanxi C&Y Pharmaceutical Group Co Ltd with three other
companies in this sector in China:
Shenzhen Neptunus Interlong Bio-technique Co Ltd
sales of 759.11 million Chinese Renmimbi [US$115.37 million]
of which 57%
was Manufacturing & selling medicine product),
Wuhan Hiteck Biological Pharma Co Ltd
(770.94 million Chinese Renmimbi [US$117.17 million]
Jiangxi Fuxiang Pharmaceutical Co Ltd
(763.68 million Chinese Renmimbi [US$116.06 million]
of which 100%
was Pharmaceutical manufacturing industry).
During the year ended December of 2016, sales at
Shanxi C&Y Pharmaceutical Group Co Ltd were 745.95 million Chinese Renmimbi (US$113.37 million).
increase of 9.1%
versus 2015, when the company's sales were 683.66 million Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Shanxi C&Y Pharmaceutical Group Co Ltd
(and since 2011, sales have increased a total of 140%).
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
71.8% in 2016, from
4.34 million Chinese Renmimbi to 7.46 million Chinese Renmimbi.
Not all segments of Shanxi C&Y Pharmaceutical Group Co Ltd experienced an increase in sales in 2016:
sales of Health Food fell 12.9% to 96.85 million Chinese Renmimbi.